Avita Medical
RCEL
51 hedge funds and large institutions have $28.6M invested in Avita Medical in 2022 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 15 increasing their positions, 9 reducing their positions, and 9 closing their positions.
2,469% more call options, than puts
Call options by funds: $668K | Put options by funds: $26K
67% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 9
56% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 9
26% more capital invested
Capital invested by funds: $22.8M → $28.6M (+$5.84M)
6% more funds holding
Funds holding: 48 → 51 (+3)
0.05% more ownership
Funds ownership: 17.24% → 17.29% (+0.05%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$785K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$453K |
| 3 |
PVI
Pura Vida Investments
New York
|
+$451K |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$294K |
| 5 |
GC
Globeflex Capital
San Diego,
California
|
+$252K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$809K |
| 2 |
CM
Caption Management
Oklahoma City,
Oklahoma
|
-$563K |
| 3 |
E
Ergoteles
New York
|
-$495K |
| 4 |
Jane Street
New York
|
-$162K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$158K |
RCEL Hedge Fund Activity: Q4 2022 in Review
51 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Avita Medical (RCEL) for Q4 2022, worth a combined $28.6M — up 26% from $22.8M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new RCEL positions and 9 closed out — a net gain of 5 holders — while 15 added to existing stakes and 9 trimmed.
The largest buyer was Millennium Management, adding an estimated $785K. The largest seller was Polar Asset Management Partners, exiting entirely with an estimated $809K sold.
- 51 institutional investors held Avita Medical (RCEL) as of Q4 2022, up from 48 in Q3 2022.
- Funds reported $28.6M of Avita Medical stock for Q4 2022, up 26% quarter-over-quarter.
- 14 funds opened new Avita Medical positions in Q4 2022 and 9 closed out, a net change of +5 holders.
- The largest Avita Medical buyer in Q4 2022 was Millennium Management, an estimated $785K added.
- The largest Avita Medical seller in Q4 2022 was Polar Asset Management Partners, an estimated $809K sold.
Based on aggregated 13F filings for Q4 2022.